Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02HSB
|
||||
Former ID |
DCL000502
|
||||
Drug Name |
Cabazitaxel
|
||||
Synonyms |
Jevtana; Taxoid XRP6258; Jevtana (TN)
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
Sanofi-Aventis
|
||||
Structure |
Download2D MOL |
||||
Formula |
C45H57NO14
|
||||
InChI |
InChI=1S/C45H57NO14/c1-24-28(57-39(51)33(48)32(26-17-13-11-14-18-26)46-40(52)60-41(3,4)5)22-45(53)37(58-38(50)27-19-15-12-16-20-27)35-43(8,36(49)34(55-10)31(24)42(45,6)7)29(54-9)21-30-44(35,23-56-30)59-25(2)47/h11-20,28-30,32-35,37,48,53H,21-23H2,1-10H3,(H,46,52)/t28-,29-,30+,32-,33+,34+,35-,37-,43+,44-,45+/m0/s1
|
||||
InChIKey |
BMQGVNUXMIRLCK-OAGWZNDDSA-N
|
||||
CAS Number |
CAS 890654-44-1
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
14816121, 16397389, 24148765, 45276379, 74383470, 99443289, 103771484, 124490495, 126731257, 131408692, 135263012, 135611139, 142086497, 152159611, 160967906, 162202442, 162224746, 163620896, 163686217, 164834203, 174007406, 175267969, 176484653, 178103404, 184812013, 189628693, 198992513, 210024082, 221678515, 223662379, 224518787, 226540589, 243273959, 249582877, 251916124, 251917472, 251971415, 252110248, 252215082
|
||||
SuperDrug ATC ID |
L01CD04
|
||||
Target and Pathway | |||||
Target(s) | Tubulin | Target Info | Inhibitor | [531351] | |
References | |||||
Ref 531351 | Mullard A: 2010 FDA drug approvals. Nat Rev Drug Discov. 2011 Feb;10(2):82-5. | ||||
Ref 541879 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6798). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.